WebJul 24, 2024 · ‘The outbreak in NSW continues to grow and the risk of disease, particularly in the Greater Sydney area, is likely to continue to be significant over coming weeks,’ ATAGI said. ‘ATAGI reaffirms our previous advice that in a large outbreak the benefits of the COVID-19 vaccine AstraZeneca are greater than the risk of rare side effects for ... WebJul 24, 2024 · ATAGI continues to closely monitor the epidemiology of COVID-19 in New South Wales, Victoria and South Australia. The outbreak in NSW continues to grow and …
COVID‐19 (Omicron strain) hospital admissions from a virtual …
WebApr 8, 2024 · Summary. ATAGI notes further evidence of a rare but serious side effect involving thrombosis (clotting) with thrombocytopenia (low blood platelet count) following receipt of COVID-19 Vaccine AstraZeneca ; ATAGI recommends that the COVID-19 vaccine by Pfizer (Comirnaty) is preferred over COVID-19 Vaccine AstraZeneca in adults aged … WebAug 1, 2024 · · Updated advice from the ATAGI with regards to interval between COVID-19 vaccine doses in an outbreak setting (13 July 2024) is incorporated. Provisional registration of the Moderna vaccine is also included. ... ATAGI statement on the use of a 3rd primary dose of COVID-19 vaccine in individuals who are severely immunocompromised Version … reach enforcement project
AstraZeneca confusion in Queensland as governments fight over …
WebDec 24, 2024 · At this time, there is no update to the ATAGI statement from 17 June 2024 in relation to the use of AstraZeneca, except to note that further clarification has been provided in regards to its use in outbreak settings. Resources. ATAGI recommends review of the following key resources: Use of AstraZeneca and/or TTS. the ATAGI/THANZ joint … WebCOVID-19 outbreak. As the COVID-19 outbreak involving the Delta variant continues to grow, the risk of contracting COVID-19 disease remains significant. ... The latest rates of TTS in Australia were published in a statement from ATAGI on 21 July 2024. While TTS is very rare, some people may have concerns that they can discuss with their doctor. ... WebMar 26, 2024 · The aims were to characterise hospital admission volume, patient epidemiology, clinical characteristics, and outcome from a virtual ward in the setting of an Omicron (BA.1, BA.2) outbreak. Methods. A retrospective observational study was performed for all virtual ward patients admitted from 1st January 2024 to 25th March … reach ending